Moderna said on Monday it expects to report around $1.9  billion in sales for 2025, putting it near the upper end of its ...

We recently published 10 Stocks Leaving Wall Street in the Dust; 4 Hit Fresh Records. Moderna Inc. (NASDAQ:MRNA) was one of ...

SAN FRANCISCO — Despite all the hopeful chatter about the life sciences industry making a rebound after a multiyear ...

Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Moderna CEO Stéphane Bancel positions 2026 as a catalyst-rich year driven by new vaccine launches, late-stage oncology data, ...

While Moderna’s full-year sales landed in the upper end of its target range, Jefferies analysts said further reductions are ...

Moderna shares are volatile Monday after the company provided updates on its business and pipeline at a healthcare conference ...

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...

Market Domination Overtime Host Josh Lipton tracks several of the day's top trending stock tickers, including Adobe's stock ...

Moderna said it expects 2025 revenue of approximately $1.9 billion, which is $100 million above the midpoint previously ...